• 澳门威尼克斯人网站

    2023.05.15

    FDA approves SinoT’s ANDA application for Mesalamine, delayed-release tablets

        Mesalamine, delayed-release tablets is an aminosalicylate indicated for the:1) induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis. 2) treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg.

    美沙拉秦肠溶片.png

        SinoT is a specialty pharma with focus on the research & development, commercialization and sale of complex generics and 505(b2) products. We dedicated to developing high quality medicines that meet with international standards. We’ll do more than our best to benefit the patients in the future.


    Shanghai Head Office

    99 Haike Road, Bldg. 3, 1st Flr., Pudong District Shanghai 201210, P.R. China

    Manufacturing Site in Jiangsu

    No. 163 Zhuhai Road, Haimen Area, Nantong City, Jiangsu Province

    Links
    Vastpro
    D-innovation
    qrcode.jpg

    Focus on us

    Copyright © 2014-2022 tongtianty.com ICP:13048014-1   Powered by Yongsy

    Privacy Legal

    友情链接: